Unknown

Dataset Information

0

Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p.


ABSTRACT: BACKGROUND:Using a toxin-induced nonhuman primate model of acute liver failure (ALF), we previously reported that peripheral infusion of human umbilical cord mesenchymal stem cells (hUC-MSCs) strongly suppresses the activation of circulating monocytes and interleukin-6 (IL-6) production, thereby disrupting the development of a cytokine storm and improving the prognosis of monkeys. MSCs are considered to play a therapeutic role under different stresses by adaptively producing specific factors, prompting us to investigate the factors that hUC-MSCs produce in response to high serum levels of IL-6, which plays a critical role in initiating and accelerating ALF. METHODS:We stimulated hUC-MSCs with IL-6, and the hUC-MSC-derived exosomes were deeply sequenced. The miRNAs in the exosomes that have potential to suppress IL-6-associated signaling pathway were screened, and the role of one of the most possible miRNAs was tested in the mouse model of inflammatory liver injury. RESULT:We determined that miR-455-3p, which is secreted through exosomes and potentially targets PI3K signaling, was highly produced by hUC-MSCs with IL-6 stimulation. The miR-455-3p-enriched exosomes could inhibit the activation and cytokine production of macrophages challenged with lipopolysaccharide (LPS) both in vivo and in vitro. In a chemical liver injury mouse model, enforced expression of miR-455-3p could attenuate macrophage infiltration and local liver damage and reduce the serum levels of inflammatory factors, thereby improving liver histology and systemic disorder. CONCLUSIONS:miR-455-3p-enriched exosomes derived from hUC-MSCs are a promising therapy for acute inflammatory liver injury.

SUBMITTER: Shao M 

PROVIDER: S-EPMC6979401 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p.

Shao Mingyang M   Xu Qing Q   Wu Zhenru Z   Chen Yuwei Y   Shu Yuke Y   Cao Xiaoyue X   Chen Menglin M   Zhang Bo B   Zhou Yongjie Y   Yao Rong R   Shi Yujun Y   Bu Hong H  

Stem cell research & therapy 20200123 1


<h4>Background</h4>Using a toxin-induced nonhuman primate model of acute liver failure (ALF), we previously reported that peripheral infusion of human umbilical cord mesenchymal stem cells (hUC-MSCs) strongly suppresses the activation of circulating monocytes and interleukin-6 (IL-6) production, thereby disrupting the development of a cytokine storm and improving the prognosis of monkeys. MSCs are considered to play a therapeutic role under different stresses by adaptively producing specific fac  ...[more]

Similar Datasets

| S-EPMC7932777 | biostudies-literature
| S-EPMC9909356 | biostudies-literature
| S-EPMC11004014 | biostudies-literature
| S-EPMC8640895 | biostudies-literature
| S-EPMC6817568 | biostudies-literature
| S-EPMC7687745 | biostudies-literature
| S-EPMC7879635 | biostudies-literature
| S-EPMC10813320 | biostudies-literature
| S-EPMC6927720 | biostudies-literature
| S-EPMC6716089 | biostudies-literature